The impact of co-expression of wild-type EGFR and its ligands determined by immunohistochemistry for response to treatment with cetuximab in patients with metastatic colorectal cancerSaid Khelwatty, Helmout Modjtahedi|Oncotarget|2016Cited by 21
Co-expression and prognostic significance of putative CSC markers CD44, CD133, wild-type EGFR and EGFRvIII in metastatic colorectal cancerSaid Khelwatty, Helmout Modjtahedi|Oncotarget|2019Cited by 19